Exelixis Inc at Stifel Healthcare Conference Transcript
All right. So we're going to go ahead and get started. I'm Steve Willey, one of the senior biotech analysts here at Stifel. I'm glad to have with us here from Exelixis, Chief Executive Officer, Mike Morrissey. We're going to have a pretty informal discussion here, just about the state of things at Exelixis. If anyone has a question, feel free to raise your hand. We'll get your question asked and addressed.
And Mike, always appreciate the time. I'm not sure if there's any kind of opening comments you want to make before we get into Q&A or little feedback.
There you go. It's good, yes. Well, thanks for the invite. Thanks for the intro. Good morning, everybody. Before I begin, I'll just remind you, I'll be making forward-looking statements today. So please see our SEC filings for a description of the risks that we face in our business.
Opening statements. Exelixis, commercial
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
